Previous studies have shown that ptprn2 is largely associated with somatic growth, and regulated by epigenetic modifications in various biological processes including hepatocellular carcinomas [56], breast cancer [57], as well as prenatal growth patterns and birthweight in humans [58]. Here, PTPRN2 is linked to hepatocellular carcinoma.